E Fund Management (HK)’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
E Fund Management (HK)'s REGN Position: Q2 2026 in Review
E Fund Management (HK) increased its Regeneron Pharmaceuticals (REGN) stake by 66% in Q2 2026, buying an estimated $168K and bringing the position to 621 shares worth $387K. The position accounts for 0.13% of the portfolio, ranked #112.
E Fund Management (HK) first reported a position in REGN in Q2 2024 and has held it in 9 quarters since. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- E Fund Management (HK) held 621 shares of Regeneron Pharmaceuticals worth $387K as of Q2 2026.
- E Fund Management (HK) bought 247 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $168K.
- Regeneron Pharmaceuticals made up 0.13% of E Fund Management (HK)'s portfolio in Q2 2026, its #112 holding.
- E Fund Management (HK) first reported a position in Regeneron Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.